Association of plaque echostructure and cardiovascular risk factors with symptomatic carotid artery disease

Vasa - Journal of Vascular Diseases

Volumn 38, Issue 4, 2009, Pages 357-364

  Giannoukas, Athanasios D ^a,b,c   Sfyroeras, G S ^a,b   Griffin, M ^a,b   Saleptsis, V ^a,b   Antoniou, G A ^a,b   Nicolaides, A N ^a,b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^c UNIVERSITY OF THESSALY   (Greece)

Author keywords

Carotid stenosis; Plaque echostructure; Risk factors; Symptomatic

Indexed keywords

C REACTIVE PROTEIN; CYANOCOBALAMIN; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LIPOPROTEIN; TRIACYLGLYCEROL;

AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SEX RATIO; SMOKING;

AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; CAROTID ARTERY, INTERNAL; CAROTID STENOSIS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; ULTRASONOGRAPHY, DOPPLER, DUPLEX;

EID: 73149101840     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.38.4.357     Document Type: Article

References (44)

1. Alvarez Garcia B, Ruiz C, Chacon P, Sabin JA, Matas M. High-sensitivity C-reactive protein in high-grade carotid stenosis: risk marker for unstable carotid plaque. J Vasc Surg. 2003 Nov; 38(5): 1018-24.
2. Asymptomatic Carotid Atherosclerosis Study (ACAS), Executive Committee. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995; 273: 1421-8.
3. Burke AP, Farb A, Mannan P, Kolodgie FD, Virmani R. C-reactive protein is expressed in unstable macrophage-rich atherosclerotic plaques [abstract]. Circulation 1997; 96(suppl I): I-492.
4. Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993; 82: 513-20.
5. Durand P, Lussier-Cacan S, Blache D. Acute methionine load-induced hyperhomocysteinemia enhances platelet aggregation, thromboxane biosynthesis, and macrophage-derived tissue factor activity in rats. FASEB J 1997; 11: 1157-68.
6. Dyken ML, Klatte E, Kolar OJ, Surgeon C. Complete occlusion of common and internal carotid arteries: Clinical significance. Arch Neurol 1974; 30: 343-7.
7. Elatrozy T, Nicolaides A, Tegos T, Griffin M. The objective characterisation of ultrasonic carotid plaque features. Eur J Vasc Endovasc Surg 1998; 16: 223-30.
8. Elatrozy T, Nicolaides A, Tegos T, Zarka AZ, Griffin M, Sabetai M. The effect of B-mode ultrasonic image standardization on the echodensity of symptomatic and asymptomatic carotid bifurcation plaques. Int Angiol 1998; 17: 179-86.
9. European Carotid Plaque Study Group. Carotid artery plaque composition - Relationship to clinical presentation and ultrasound B-mode imaging. Eur J Vasc Endovasc Surg 1995; 10: 23-30.
10. European Carotid Surgery Trialists Collaborative Group. Risk of stroke in the distribution of an asymptomatic carotid artery. Lancet 1995; 345: 209-12.
11. European Carotid Surgery Trialists' Collaborative Group. Endarterectomy for moderate symptomatic carotid stenosis: Interim results for symptomatic patients from the MRC European Carotid Surgery Trial. Lancet 1996; 347: 1591-3.
12. European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: Interim results for symptomatic patients with severe (70%-99%) or with mild (0%-29%) carotid stenosis. Lancet 1991; 337: 1235-43.
13. Fortunato JE, Bassiouny HS, Song RH, Kocharian H, Glagov S, Edelstein C, Scanu AM. Apolipoprotein (a) fragments in relation to human carotid plaque instability. J Vasc Surg 2000; 32: 555-63.
14. Glagov S, Bassiouny HS, Sakaguchi CA, Goudet CA, Vito RP. Mechanical determinants of plaque modeling, remodeling and disruption. Atherosclerosis 1997; 131 (Suppl): S13-S14.
15. Gronholdt ML, Nordestgaard BG, Schroeder TV, Vorstrup S, Sillesen H. Ultrasonic echolucent carotid plaques predict future strokes. Circulation 2001; 104: 68-73.
16. Gronholdt MLM, Nordestgaard BG, Nielsen TG, Sillesen H. Echolucent carotid artery plaques are associated with elevated levels of fasting and postprandial triglyceride-rich lipoproteins. Stroke 1996; 27: 2166-72.
17. Gronholdt MLM, Nordestgaard BG, Wiebe BM, Wilhjelm FE, Sillesen H. Echolucency of computerized ultrasound images of carotid atherosclerotic plaques are associated with increased levels of triglyceride-rich lipoproteins as well as increased plaque lipid content. Circulation 1998; 97: 34-40.
18. Gronholdt MLM, Wiebe BM, Laursen H, Nielsen TG, Schroeder TV, Sillesen H. Lipid-rich carotid artery plaques may appear echolucent on ultrasound B-mode images and may be associated with intraplaque haemorrhage. Eur J Vasc Endovasc Surg 1997; 14: 439-45.
19. Holdsworth RJ, McCollum PT, Bryce JS, Harrison DK. Symptoms, stenosis and carotid plaque morphology. Is plaque morphology relevant? Eur J Vasc Endovasc Surg 1995; 8: 80-5.
20. Kang SS, Wong PW, Malinow MR. Hyperhomocysteinemia as a risk factor for occlusive vascular disease. Ann Rev Nutr 1992; 12: 279-98.
21. Koennecke HC. Carotid stenosis - when is revascularization appropriate? Vasa 38; 2009: 203-11.
22. Ku D, Giddens DP, Zarins C, Glagov S. Pulsate flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low and oscillating stress. Arteriosclerosis 1985; 5: 293-302.
23. Lupattelli G, Rufini S, Locati EH, Lombardini R, Ciuffetti G, Siepi D, Mannarino E. Hyperhomocyst(e)inemia is associated with carotid atherosclerosis. Angiology 1999; 50: 823-30.
24. Mathiesen EB, Bønaa KH, Joakimsen O. Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the tromsø study. Circulation. 2001 May 1; 103(17): 2171-5.
25. Moneta GL, Edwards JM, Papanicolaou G, Hatsukami T, Taylor LM Jr, Strandness DE Jr, Porter JM. Screening for asymptomatic internal carotid artery stenosis: duplex criteria for discriminating 60 % to 99 % stenosis. J Vasc Surg 1995; 21: 989-94.
26. MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004; 363: 1491-502.
27. Nguyen TT, Ellefson RD, Hodge DO, Bailey KR, Kottke TE, Abu-Lebdeh HS. Predictive value of electrophoretically detected lipoprotein (a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9936 men and women. Circulation 1997; 96: 1390-7.
28. Nicolaides AN, Kakkos SK, Griffin M, Sabetai M, Dhanjil S, Thomas DJ, Geroulakos G, Georgiou N, Francis S, Ioannidou E, Doré CJ; Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group. Effect of image normalization on carotid plaque classification and the risk of ipsilateral hemispheric ischemic events: results from the asymptomatic carotid stenosis and risk of stroke study. Vascular. 2005 Jul-Aug;13(4): 211-21.
29. Nicolaides AN, Shifrin EG, Bradbury A, Dhanjil S, Griffin M, Belcaro G Williams M. Angiographic and duplex grading of internal carotid stenosis: can we overcome the confusion? J Endovasc Surg 1996; 3: 158-65.
30. North American Symptomatic Carotid Endarterectomy Trial Collaborators (NASCET). Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325: 445-53.
31. Petersen NH, Schmied AB, Zeller JA, Plendl H, Deuschl G, Zunker P. Lp(a) lipoprotein and plasminogen activity in patients with different etiology of ischemic stroke. Cerebrovasc Dis. 2007; 23 (2-3): 188-93.
32. Rerkasem K, Shearman CP, Williams JA, Morris GE, Phillips MJ, Calder PC, Grimble RF. C-reactive protein is elevated in symptomatic compared with asymptomatic patients with carotid artery disease. Eur J Vasc Endovasc Surg. 2002 Jun; 23(6): 505-9.
33. Richardson RD, Davies MJ, Born GRV. Influence of plaque confi guration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet 1989; 21: 941-4.
34. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998; 97: 425-8.
35. Ridker PM. C-reactive protein and risks of future myocardial infarction and thrombotic stroke. Eur Heart J 1998;19:1-3.
36. Rodgers GM, Conn MT. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood 1990; 75: 895-901.
37. Sabetai MM, Tegos TJ, Clifford C, Dhanjil S, Belcaro G, Kalodiki E, Stevens JM, Nicolaides AN. Carotid plaque echogenicity and types of silent CT-brain infarcts. Is there any association in patients with asymptomatic carotid stenosis? Int Angiol 2001; 20: 51-7.
38. Sabetai MM, Tegos TJ, Nicolaides AN, El-Atrozy TS, Dhanjil S, Griffin M, Belcaro G, Geroulakos G. Hemispheric symptoms and carotid plaque echomorphology. J Vasc Surg 2000; 31: 39-49.
39. Seeger JM, Barratt E, Lawson GA, Klingman N. The relationship between carotid plaque composition, plaque morphology, and neurologic symptoms. J Surg Res 1995; 58: 330-6.
40. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PW, O'Leary DH, Wolf PA, Schaefer EJ, Rosenberg IH. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995; 332: 286-91.
41. Tanne D, Haim M, Goldbourt U, Boyko V, Doolman R, Adler Y, Brunner D, Behar S, Sela BA. Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease. Stroke. 2003 Mar; 34 (3): 632-6.
42. Tegos TJ, Sabetai MM, Nicolaides AN, Elatrozy TS, Dhanjil S, Stevens JM. Patterns of brain computed tomography infarction and carotid plaque echogenicity. J Vasc Surg. 2001 Feb; 33 (2): 334-9.
43. Wilson PWF, D' Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-47.
44. Wolbink GJ, Brouwer MC, Buysmann S, ten Berge IJ, Hack CE. CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C reacting protein complexes. J Immunol 1996; 157: 473-9.